Expression of CD276 in ccRCC specimens is correlated with adverse clinicopathologic outcomes (tumor size, tumor stage, nuclear grading, coagulative tumor necrosis, and sarcomatoid differentiation). The gene discussed is CD276; the disease is nonpapillary renal cell carcinoma.